(1) Fong CW. Molecular mechanisms of cellular transport, resistance and cytotoxic side effects of platinum and adjuvant anti-cancer drugs–a molecular orbital study. J. Comput. Chem. (2017) 3: 185.
(2) Santabarbara G, Maione P, Rossi A and Gridelli C. Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy. Expert Opin. Pharmacother. (2016) 17: 561-70.
(3) Nardon C, Boscutti G and Fregona D. Beyond Platinums: gold complexes as anticancer agents. Anticancer Res. (2014) 34: 487-92.
(4) Raubenheimer HG and Schmidbaur H. The late start and amazing upswing in gold chemistry. J. Chem. Educ. (2014) 91: 2024-36.
(5) Đurović MD, Bugarčić ŽD and van Eldik R. Stability and reactivity of gold compounds – From fundamental aspects to applications. Coord. Chem. Rev. (2017) 338: 186-206.
(6) Hutchings GJ, Brust M and Schmidbaur H. Gold-an introductory perspective. Chem. Soc. Rev. (2008) 37: 1759-65.
(7) Mohr F. Gold Chemistry: Applications and Future Directions in the Life Sciences. 2nd ed. Wiley-VCH Publisher, New Jersey (2009) 47-92.
(8) Laguna A, Modern Supramolecular Gold Chemistry: Gold-Metal Interactions and Applications. Wiley-VCH Publisher, New Jersey (2008) 1-63.
(9) Schmidbaur H. Ludwig Mond Lecture. High-carat gold compounds. Chem. Soc. Rev. (1995) 24: 391-400.
(10) Hao L, Mansour MA, Lachicotte RJ, Gysling HJ and Eisenberg R. A gold(I) mononuclear complex and its association into binuclear and cluster compounds by hydrogen bonding or metal ion coordination. Inorg. Chem. (2000) 39: 5520-9.
(11) Robson JA, Gonzàlez de Rivera F, Jantan KA, Wenzel MN, White AJP, Rossell O and Wilton-Ely JDET. Bifunctional chalcogen linkers for the stepwise generation of multimetallic assemblies and functionalized nanoparticles. Inorg. Chem. (2016) 55: 12982-96.
(12) Zou T, Lum CT, Lok CN, Zhang JJ and Che CM. Chemical biology of anticancer gold(III) and gold(I) complexes. Chem. Soc. Rev. (2015) 44: 8786-801.
(13) Atrián-Blasco E, Gascón S, Rodrı́guez-Yoldi MJ, Laguna M and Cerrada E. Novel gold(I) thiolate derivatives synergistic with 5-fluorouracil as potential selective anticancer agents in colon cancer. Inorg. Chem. (2017) 56: 8562-79.
(14) Malwitz MA, Lim SH, White-Morris RL, Pham DM, Olmstead MM and Balch AL. Crystallization and interconversions of vapor-sensitive, luminescent polymorphs of [(C6H11NC)2AuI](AsF6) and [(C6H11NC)2AuI](PF6). J. Am. Chem. Soc. (2012) 134: 10885-93.
(15) Schneider W, Angermaier K, Sladek A and Schmidbaur H. Ligand influences on the Supramolecular chemistry of simple gold(I) complexes: mononuclear (Isonitrile)gold(I) complexes. Z. Naturforsch. B (1996) 51: 790-800.
(16) Manzano R, Rominger F and Hashmi ASK. Saturated abnormal NHC–Gold(I) complexes: synthesis and catalytic activity. Organometallics (2013) 32: 2199-203.
(17) Collado A, Gomez-Suarez A, Martin AR, Slawin AMZ and Nolan SP. Straightforward synthesis of [Au(NHC)X] (NHC = N-heterocyclic carbene, X = Cl, Br, I) complexes. Chem. Commun. (2013) 49: 5541-3.
(18) Han Z, Bates JI, Strehl D, Patrick BO and Gates DP. Homo- and heteropolynuclear complexes containing bidentate bridging 4-phosphino-N-heterocyclic carbene ligands. Inorg. Chem. (2016) 55: 5071-8.
(19) Seki T, Sakurada K, Muromoto M, Seki S and Ito H. Detailed investigation of the structural, thermal, and electronic properties of gold isocyanide complexes with mechano-triggered single-crystal-to-single-crystal phase transitions. Chem. Eur. J. (2016) 22: 1968-78.
(20) Johnson A and Gimeno MC. An efficient and sustainable synthesis of NHC gold complexes. Chem. Commun. (2016) 52: 9664-7.
(21) Ott I. On the medicinal chemistry of gold complexes as anticancer drugs. Coord. Chem. Rev. (2009) 253: 1670-81.
(22) Joao Carlos L and Laura R. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action. Anti-Cancer Agents Med. Chem. (2011) 11: 921-8.
(23) García-Moreno E, Gascón S, Atrián-Blasco E, Rodriguez-Yoldi MJ, Cerrada E and Laguna M. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs. Eur. J. Med. Chem. (2014) 79: 164-72.
(24) Dadkhah Aseman M, Nabavizadeh SM, Shahsavari HR and Rashidi M. C-H reductive elimination during the reaction of cycloplatinated(II) complexes with pyridine-2-thione: Kinetic follow up. RSC Adv. (2015) 5: 22692-702.
(25) Fereidoonnezhad M, Niazi M, Ahmadipour Z, Mirzaee T, Faghih Z, Faghih Z and Shahsavari HR. Cyclometalated platinum(II) complexes comprising 2-(diphenylphosphino)pyridine and various thiolate ligands: Synthesis, spectroscopic characterization and biological activity. Eur. J. Inorg. Chem. (2017) 2247–54.
(26) Niazi M, Shahsavari HR, Golbon Haghighi M, Halvagar MR, Hatami S and Notash B. Carbon-sulfur bond reductive coupling from a platinum(II) thiolate complex. RSC Adv. (2016) 6: 95073-84.
(27) Raper ES. Complexes of heterocyclic thionates. Part 1. Complexes of monodentate and chelating ligands. Coord. Chem. Rev. (1996) 153: 199-255.
(28) Dyadchenko VP, Belov NM, Lemenovskii DA, Antipin MY, Lyssenko KA, Bruce AE and Bruce MRM. Synthesis, crystal and molecular structure of gold(I) thiophenolate with 4′-ferrocenyl[1,1′]biphenylisocyanides. J. Organomet. Chem. (2010) 695: 304-9.
(29) Römbke P, Schier A, Wiesbrock F, and Schmidbaur H. Gold(I) thiosulfonate complexes. Inorg. Chim. Acta (2003) 347: 123-8.
(30) Schneider W, Bauer A and Schmidbaur H. (Isocyanide)gold(I) thiosalicylates: supramolecular assembly based on both auriophilic and hydrogen bonding. Organometallics (1996) 15: 5445-6.
(31) Dyadchenko VP, Belov NM, Dyadchenko MA, Slovokhotov YL, Banaru AM and Lemenovskii DA. A complex of gold(I) benzenethiolate with isocyanide: synthesis and crystal and molecular structures. Russ. Chem. Bull., Int. Ed. (2010) 59: 539-43.
(32) Gutierrez A, Cativiela C, Laguna A and Gimeno MC. Bioactive gold(I) complexes with 4-mercaptoproline derivatives. Dalton Trans. (2016) 45: 13483-90.
(33) Hokai Y, Jurkowicz B, Fernández-Gallardo J, Zakirkhodjaev N, Sanaú M, Muth TR and Contel M. Auranofin and related heterometallic gold(I)–thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains. J. Inorg. Biochem. (2014) 138: 81-8.
(34) Dada O, Curran D, O'Beirne C, Müller-Bunz H, Zhu X and Tacke M. Synthesis and cytotoxicity studies of novel NHC–Gold(I) pseudohalides and thiolates. J. Organomet. Chem. (2017) 840: 30-7.
(35) Chia EY, Naeem S, Delaude L, White AJP and Wilton-Ely JDET. Gold(i) complexes bearing mixed-donor ligands derived from N-heterocyclic carbenes. Dalton Trans. (2011) 40: 6645-58.
(36) Mui YF, Fernández-Gallardo J, Elie BT, Gubran A, Maluenda I, Sanaú M, Navarro O and Contel Ma. Titanocene–Gold Complexes Containing N-heterocyclic carbene ligands inhibit growth of prostate, renal, and colon cancers in-vitro. Organometallics (2016) 35: 1218-27.
(37) Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A and Messori L. Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs. Coord. Chem. Rev. (2009) 253: 1692-707.
(38) Pia Rigobello M, Messori L, Marcon G, Agostina Cinellu M, Bragadin M, Folda A, Scutari G and Bindoli A. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions. J. Inorg. Biochem. (2004) 98: 1634-41.
(39) Serebryanskaya TV, Lyakhov AS, Ivashkevich LS, Schur J, Frias C, Prokop A and Ott I. Gold(i) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents. Dalton Trans. (2015) 44: 1161-9.
(40) Gratteri P, Massai L, Michelucci E, Rigo R, Messori L, Cinellu MA, Musetti C, Sissi C and Bazzicalupi C. Interactions of selected gold(iii) complexes with DNA G quadruplexes. Dalton Trans. (2015) 44: 3633-9.
(41) Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P, Mazzei T, Cinellu MA and Minghetti G. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. J. Med. Chem. (2002) 45: 1672-7.
(42) Fereidoonnezhad M, Kaboudin B, Mirzaee T, Babadi Aghakhanpour R, Golbon Haghighi M, Faghih Z, Faghih Z, Ahmadipour Z, Notash B and Shahsavari HR. Cyclometalated platinum(II) complexes bearing bidentate O,O′-Di(alkyl)dithiophosphate ligands: photoluminescence and cytotoxic properties. Organometallics (2017) 36: 1707−17.
(43) Fereidoonnezhad M, Niazi M, Shahmohammadi Beni M, Mohammadi S, Faghih Z, Faghih Z and Shahsavari HR. Synthesis, biological evaluation, and molecular docking studies on the DNA binding interactions of platinum(II) rollover complexes containing phosphorus donor ligands. ChemMedChem (2017) 12: 456-65.
(44) Mojaddami A, Sakhteman A, Fereidoonnezhad M, Faghih Z, Najdian A, Khabnadideh S, Sadeghpour H and Rezaei Z. Binding mode of triazole derivatives as aromatase inhibitors based on docking, protein ligand interaction fingerprinting, and molecular dynamics simulation studies. Res. Pharm. Sci. (2017) 12: 21-30.
(45) Zare S, Fereidoonnezhad M, Afshar D and Ramezani Z. A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors. Comput. Biol. Chem. (2017) 67: 22-37.
(46) Fereidoonnezhad M, Faghih Z, Mojaddami A, Tabaei SMH and Rezaei Z. Novel approach synthesis, molecular docking and cytotoxic activity evaluation of N-phenyl-2,2-dichloroacetamide derivatives as anticancer agents. J. Sci. Islam. Repub. Iran (2016) 27: 39-49.
(47) Fereidoonnezhad M, Faghih Z, Mojaddami A, Sakhteman A and Rezaei Z. A comparative docking studies of dichloroacetate analogues on four isozymes of pyruvate dehydrogenase kinase in humans. Indian J. Pharm. Edu. Res. (2016) 50: S32-S8.
(48) DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 Newsletter On Protein Crystallography (2002) 40: 82-92.
(49) Brandys MC, Jennings MC and Puddephatt RJ. Luminescent gold(I) macrocycles with diphosphine and 4,4'-bipyridyl ligands. J. Chem. Soc., Dalton Trans. (2000) 2000: 4601-6.
(50) Hojoh K, Ohmiya H and Sawamura M. Synthesis of α-Quaternary formimides and aldehydes through umpolung asymmetric copper catalysis with isocyanides. J. Am. Chem. Soc. (2017) 139: 2184-7.
(51) Zakrzewski J, Huras B and Kiełczewska A. Synthesis of isoselenocyanates. Synthesis (2016) 48: 85-96.
(52) Fereidoonnezhad M, Shahsavari HR, Lotfi E, Babaghasabha M, Fakhri M, Faghih Z, Faghih Z and Hassan Beyzavi M. (Benzyl isocyanide) gold (I) pyrimidine‐2‐thiolate complex: Synthesis and biological activity. Appl. Organomet. Chem. (2018) 32: 1-7.
(53) Zou T, Lum CT, Lok CN, Zhang JJ and Che CM. Chemical biology of anticancer gold(iii) and gold(i) complexes. Chem. Soc. Rev. (2015) 44: 8786-801.